Edward George, MD
Hematology-Oncology · Norfolk, VANPI 1407851256
Payments from drug & device makers
Across 422 payments — averaging $764.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$133K
- Amgen$76K
- Rigel Pharmaceuticals, Inc.$36K
- Sanofi$32K
- EUSA Pharma (US) LLC$21K
- Array Biopharma Inc$6K
- plus $19K from 25 others
What the payments were for
- Consulting fees$50,13916%
- Speaking & faculty fees$231,03472%
- Travel & lodging$29,8819%
- Food & beverage$11,5944%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 173 | $133,386 |
| Amgen | 101 | $75,873 |
| Rigel Pharmaceuticals, Inc. | 49 | $35,511 |
| Sanofi | 27 | $31,959 |
| EUSA Pharma (US) LLC | 16 | $21,384 |
| Array Biopharma Inc | 7 | $5,619 |
| Catalyst Pharmaceuticals, Inc. | 5 | $3,662 |
| AbbVie(2 entities) | 5 | $3,205 |
| Bristol Myers Squibb | 1 | $1,695 |
| GSK | 1 | $1,625 |
| Karyopharm Therapeutics Inc. | 1 | $1,550 |
| G1 Therapeutics, Inc. | 1 | $1,500 |
| Gilead(2 entities) | 4 | $1,209 |
| Immunomedics, Inc. | 1 | $1,000 |
| Incyte Corporation | 4 | $459 |
| Dova Pharmaceuticals | 3 | $361 |
| Athenex Pharmaceutical Division, LLC | 2 | $350 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $340 |
| Seagen Inc. | 2 | $249 |
| Merck | 2 | $241 |
| Genentech USA, Inc. | 2 | $239 |
| Astellas Pharma US Inc | 2 | $222 |
| Novocure GmbH | 1 | $200 |
| Taiho Oncology, Inc. | 1 | $125 |
| EMD Serono, Inc. | 1 | $120 |
| Pharmaessentia USA Corporation | 1 | $120 |
| Adaptive Biotechnologies Corporation | 1 | $102 |
| Ipsen Biopharmaceuticals, Inc | 1 | $94 |
| Stemline Therapeutics Inc. | 1 | $87 |
| E.r. Squibb & Sons, L.L.C. | 1 | $87 |
| Lilly USA, LLC | 2 | $84 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few hematology-oncology providers in Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology-oncology in Norfolk
- Scott CrossNorfolk$1.6M
- Paul ConklingNorfolk$609K
- Burton AlexanderNorfolk$612
- Michael LeeNorfolk$501
- John PascholdWilliamsburg$873K
- Ravneet GrewalLansdowne$10K
- Valiant TanChesapeake$3K
- David PowellHampton$610
- John KesslerNewport News$194
- Kathryn CappellFairfax$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.